Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05980897 · ClinicalTrials.gov registry record · NA
Inner Speech and Naming Treatment for Individuals with Aphasia
A NA study of Aphasia and Language Disorders, sponsored by George Washington University.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT05980897 is a NA study of Aphasia and Language Disorders that has completed, run by George Washington University. The registered enrollment target is 10 participants, below the 83-participant average among 42 other Aphasia trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05980897, a NA study of Aphasia and Language Disorders, has completed, sponsored by George Washington University.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
Aphasia is a language disorder, commonly resulting from stroke or other brain injury, that impacts a person's ability to communicate. This project is looking to improve upon current treatment methods for spoken naming in people with aphasia. People with aphasia frequently report being able to successfully say a word in their head, regardless of their ability to say the word out loud. For example, when presented with a picture of a house, they may report being able to think or hear "house" in their head, even if they can't name it out loud. This "little voice" inside one's head is known as inner speech (IS). Previous research suggests that some people with aphasia can re-learn to say words with successful IS (i.e., words they can already say in their heads) easier and faster than words with unsuccessful IS. This study will extend these findings by implementing a comparative treatment study in a larger group of participants with aphasia. The results will help to establish recommendations for speech-language pathologists in choosing treatment stimuli for anomia.
Conditions Studied
Interventions
- BEHAVIORAL Naming treatment
Study Locations (1)
District of Columbia
- The George Washington University - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2023-07-05 |
| Est. Completion | 2024-05-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05980897
The ClinicalTrials.gov registry entry for NCT05980897 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 83-participant average among 42 other Aphasia trials with a reported enrollment target (88% lower). The listed sponsor is George Washington University, which has 133 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Aphasia appearing as the primary indexed condition, and to 1 intervention - of which Naming treatment is the first listed.
NCT05980897 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.
Frequently Asked Questions
What is clinical trial NCT05980897 about?
NCT05980897 is a clinical study titled "Inner Speech and Naming Treatment for Individuals with Aphasia". Aphasia is a language disorder, commonly resulting from stroke or other brain injury, that impacts a person's ability to communicate. This project is looking to improve upon current treatment methods for spoken naming in people with aphasia. People with aphasia frequently report being able to succes...
What is the current status of trial NCT05980897?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2023-07-05. Estimated completion is 2024-05-01.
What conditions does trial NCT05980897 study?
This clinical trial studies the following conditions: Aphasia, Language Disorders, Communication Disorders, Anomia.
What interventions are being tested in trial NCT05980897?
The interventions under investigation include: Naming treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT05980897?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05980897 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aphasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Transcranial Alternating Current Stimulation (tACS) in Aphasia
RECRUITING · NA
-
tACS to Enhance Language Abilities
RECRUITING · NA
-
Treatment Outcomes With tDCS in Post-Stroke Aphasia
RECRUITING · NA
-
Telerehabilitation for Aphasia (TERRA)
RECRUITING · NA
-
Combined Exercise and Targeted Therapy for Post-Stroke Reading Deficits
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.